Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cel-Sci Corp (AMEX:CVM) (was HIV) -- Ignore unavailable to you. Want to Upgrade?

To: LT who wrote (2766)	1/21/2000 1:49:00 PM
From: Tom Shutters	Read Replies (1) \| Respond to of 2836

Biotech industry gets Clinton's endorsement cbs.marketwatch.com

To: LT who wrote (2766)	1/24/2000 2:18:00 PM
From: Toni Wheeler	Read Replies (1) \| Respond to of 2836

from Yahoo!.....HIV board: 'pharmascoop' reveals info on HIV....: messages.yahoo.com Talked to Investor Relations by: pharmascoop 1/22/00 5:27 pm Msg: 13180 of 13199 <<<For those long on the stock...I spoke to Darryl in Investor relations late last week. Of course she had nothing specific to say because she could not give that information even if she had it but several hints were excellent news to me...Look for article in major scientific journal on one of the concluded studies anytime now...Paper is in its last review stage by the editors now...The key things in the data will be tumor reduction rates and FOLLOW-UP PROGRESS REPORTS...i.e.THESE PEOPLE ARE STILL ALIVE...Great quality of life issues with this MULTIKINE drug...Once we break thru $4 range there will be little resistance...Finially, after article and price above $5, we can get BIG BLOCKS from institutional investors whom are currently limited to investing in stocks under $5. Good luck to all longs and thanks to fmrick, sol, and other regulars on this site who keep us others up to date.>>> messages.yahoo.com phase III initiation by: pharmascoop 1/23/00 5:12 pm Msg: 13200 of 13245 <<TO all..although I can't tell exact specifics, I can tell you that Cel-Sci has been in contact with a particular CRO in regards to phase III studies. To those that know the science they know that cGMP guidelines and regulations must be followed for this...The CRO coupled with Cel-Sci new regulatory affairs person will have to work hand in hand...All looks good on the Multikine front..I expect steady rise up to $12 range prior to official start of phase III...Make your own investment decisions by performing DD.>>> 'CRO' explained by 'downriggers' <<<CRO is a contract research organization and they perform functions such as formulations development, analytical development, synthetic development, clinical trials design, clinical trials monitoring, etc...Quintiles Transnational (QTRN) is the largest player although there are quite a few.>>>